Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01827670 · ClinicalTrials.gov registry record · Phase 3
Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 119
- Enrollment target
NCT01827670 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 119 participants.
The verdict
NCT01827670, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 119 participants
- Enrollment target
Study Summary
Clinical studies have demonstrated long term relief from dentine hypersensitivity with twice daily brushing of a toothpaste containing stannous fluoride in comparison to marketed (negative) controls. The aim of this study is to evaluate the effectiveness of a stannous fluoride dentifrice in the treatment of dentinal hypersensitivity compared to a marketed (negative) control, over a period of 56 days (8 weeks) with twice daily brushing.
Interventions
- DRUG Stannous fluoride
- DRUG Sodium monofluorophosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01827670
The ClinicalTrials.gov registry entry for NCT01827670 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stannous fluoride is the first listed.
NCT01827670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01827670 about?
NCT01827670 is a clinical study titled "Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity". Clinical studies have demonstrated long term relief from dentine hypersensitivity with twice daily brushing of a toothpaste containing stannous fluoride in comparison to marketed (negative) controls. The aim of this study is to evaluate the effectiveness of a stannous fluoride dentifrice in the trea...
What is the current status of trial NCT01827670?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 119 participants. The study started on 2013-02. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01827670?
The interventions under investigation include: Stannous fluoride (DRUG), Sodium monofluorophosphate (DRUG).
Who is sponsoring clinical trial NCT01827670?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.